Brexanolone injection in post-partum depression: two multicentre, double-blind, randomised, placebo-controlled, phase 3 trials
Samantha Meltzer‐Brody(University of North Carolina at Chapel Hill), Stephen Kanes(Sage Therapeutics (United States)), Robert Riesenberg, Amy Schacterle(Sage Therapeutics (United States)), Abdul J. Sankoh(Sage Therapeutics (United States)), C. Neill Epperson(University of Pennsylvania), Kristina M. Deligiannidis(Zucker Hillside Hospital), Helen Colquhoun(Sage Therapeutics (United States)), Haihong Li(Qufu Normal University), David R. Rubinow(University of North Carolina at Chapel Hill), Jeffrey M. Jonas(Sage Therapeutics (United States)), Christine Clemson(Sage Therapeutics (United States))
Cited by 780
Related Papers
Effects of Gonadal Steroids in Women With a History of Postpartum Depression
|American Journal of Psychiatry|2000|942
Differential Behavioral Effects of Gonadal Steroids in Women with and in Those without Premenstrual Syndrome
|New England Journal of Medicine|1998|766
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
|The Journal of Clinical Endocrinology & Metabolism|2010|678
The epidemiology of DSM-III-R bipolar I disorder in a general population survey
|Psychological Medicine|1997|605
Menstrual cycle phase modulates reward-related neural function in women
|Proceedings of the National Academy of Sciences|2007|586